Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis
- PMID: 11786970
- DOI: 10.1053/jhep.2002.30082
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis
Abstract
The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis. We conducted a prospective evaluation of all bacterial infections diagnosed in patients with cirrhosis in a Liver Unit between April 1998 and April 2000. A total of 405 patients presented 572 bacterial infections in 507 admissions. Spontaneous bacterial peritonitis was the most frequent infection (138 cases). Gram-positive cocci were responsible for 53% of total bacterial infections in the study, being the main bacteria isolated in nosocomial infections (59%). Patients requiring treatment in an intensive care unit and those submitted to invasive procedures presented a higher rate of infections caused by gram-positive cocci (77% vs. 48%, P <.001 and 58% vs. 40%, P <.02, respectively). Fifty percent of culture-positive spontaneous bacterial peritonitis in patients on long-term norfloxacin administration (n = 93) and 16% in patients not receiving this therapy (n = 414) were caused by quinolone-resistant gram-negative bacilli, P =.01. The rate of culture-positive spontaneous bacterial peritonitis caused by trimethoprim-sulfamethoxazole-resistant gram-negative bacilli was also very high in patients on long-term norfloxacin administration (44% vs. 18%, P =.09). In conclusion, infections caused by gram-positive cocci have markedly increased in cirrhosis. This phenomenon may be related to the current high degree of instrumentation of cirrhotic patients. Quinolone-resistant spontaneous bacterial peritonitis constitutes an emergent problem in patients on long-term norfloxacin prophylaxis, with trimethoprim-sulfamethoxazole not being a valid alternative.
Similar articles
-
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.Hepatology. 1997 Mar;25(3):532-6. doi: 10.1002/hep.510250306. Hepatology. 1997. PMID: 9049193 Clinical Trial.
-
Trimethoprim-sulfamethoxazole versus norfloxacin in the prophylaxis of spontaneous bacterial peritonitis in cirrhosis.Arq Gastroenterol. 2005 Oct-Dec;42(4):256-62. doi: 10.1590/s0004-28032005000400012. Epub 2006 Jan 19. Arq Gastroenterol. 2005. PMID: 16444382 Clinical Trial.
-
Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.Hepatology. 1999 Apr;29(4):1064-9. doi: 10.1002/hep.510290406. Hepatology. 1999. PMID: 10094947
-
[Bacterial infections in liver cirrhosis].Orv Hetil. 2007 Mar 4;148(9):387-95. doi: 10.1556/OH.2007.27882. Orv Hetil. 2007. PMID: 17344166 Review. Hungarian.
-
Efficacy of Norfloxacin Prophylaxis to Prevent Spontaneous Bacterial Peritonitis: A Systematic Review and Meta-Analysis.Clin Transl Gastroenterol. 2020 Aug;11(8):e00223. doi: 10.14309/ctg.0000000000000223. Clin Transl Gastroenterol. 2020. PMID: 32955202 Free PMC article.
Cited by
-
The feasibility and safety of the endoscopic submucosal dissection of superficial gastric neoplastic lesions in patients with compensated liver cirrhosis: a retrospective study.Gut Liver. 2012 Jan;6(1):58-63. doi: 10.5009/gnl.2012.6.1.58. Epub 2012 Jan 12. Gut Liver. 2012. PMID: 22375172 Free PMC article.
-
Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models.Respir Res. 2018 Dec 4;19(1):242. doi: 10.1186/s12931-018-0934-5. Respir Res. 2018. PMID: 30514312 Free PMC article.
-
Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1.Dig Dis Sci. 2008 Jul;53(7):1757-73. doi: 10.1007/s10620-007-0079-8. Epub 2007 Nov 9. Dig Dis Sci. 2008. PMID: 17990105 Review.
-
Transjugular intrahepatic portosystemic shunt in liver transplant recipients.World J Gastroenterol. 2009 Apr 28;15(16):1999-2004. doi: 10.3748/wjg.15.1999. World J Gastroenterol. 2009. PMID: 19399933 Free PMC article.
-
Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study.Tzu Chi Med J. 2019 Feb 18;32(1):47-52. doi: 10.4103/tcmj.tcmj_142_18. eCollection 2020 Jan-Mar. Tzu Chi Med J. 2019. PMID: 32110520 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous